Expression of tumour necrosis factor‐α and its receptors in Hodgkin lymphoma
暂无分享,去创建一个
T. Hanafusa | A. Takayama | M. Tsuji | T. Yokote | T. Akioka | T. Miyoshi | S. Nakayama | N. Hiraoka | K. Iwaki | Y. Hirata | U. Nishiwaki | Y. Masuda
[1] W. Choi,et al. CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. , 2013, Blood.
[2] Wen-Qi Jiang,et al. CD20-negative de novo diffuse large B-cell lymphoma in HIV-negative patients: A matched case-control analysis in a single institution , 2012, Journal of Translational Medicine.
[3] E. Podack,et al. CD30: an important new target in hematologic malignancies , 2011, Leukemia & lymphoma.
[4] T. Economopoulos,et al. A clinicopathological study of B-cell differentiation markers and transcription factors in classical Hodgkin’s lymphoma: a potential prognostic role of MUM1/IRF4 , 2007, Haematologica.
[5] K. Naresh,et al. Circulating levels of TNFα and TNF receptor superfamily members in lymphoid neoplasia , 2000 .
[6] H. Stein,et al. Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. , 2000, Blood.
[7] B. Coiffier,et al. ELEVATED CIRCULATING LEVELS OF TNFα AND ITS p55 SOLUBLE RECEPTOR ARE ASSOCIATED WITH AN ADVERSE PROGNOSIS IN LYMPHOMA PATIENTS , 1996, British journal of haematology.
[8] F. Herrmann,et al. The significance of serum levels of soluble 60kDa receptors for tumor necrosis factor in patients with Hodgkin's disease. , 1993, Leukemia.
[9] K. Lennert,et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. , 1985, Blood.
[10] Joseph Mainzer,et al. FOR THE EXPRESSION , 2013 .
[11] H. Ioniță,et al. B-cell transcription factors Pax-5, Oct-2, BOB.1, Bcl-6, and MUM1 are useful markers for the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma. , 2011, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.
[12] K. Naresh,et al. Circulating levels of TNF alpha and TNF receptor superfamily members in lymphoid neoplasia. , 2000, American journal of hematology.